Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA001728-05
Application #
2084381
Study Section
Special Emphasis Panel (SRC (72))
Project Start
1992-09-01
Project End
1997-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Cohen, Steven J; Alpaugh, R Katherine; Gross, Steve et al. (2006) Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 6:125-32
Sundermeyer, Mark L; Meropol, Neal J; Rogatko, Andre et al. (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5:108-13
Lewis, N L; Mullaney, M; Mangan, K F et al. (2004) Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients. Bone Marrow Transplant 33:71-8
Cohen, Steven J; Gallo, James; Lewis, Nancy L et al. (2004) Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer. Cancer Chemother Pharmacol 53:513-8
Cohen, Steven J; Ho, Linus; Ranganathan, Sulabha et al. (2003) Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol 21:1301-6
Cheng, Jonathan D; Dunbrack Jr, Roland L; Valianou, Matthildi et al. (2002) Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62:4767-72
von Mehren, M; Arlen, P; Gulley, J et al. (2001) The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res 7:1181-91
von Mehren, M; Arlen, P; Tsang, K Y et al. (2000) Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res 6:2219-28
Siegelmann-Danieli, N; Buetow, K H (1999) Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Br J Cancer 79:456-63
Siegelmann-Danieli, N; Hanlon, A; Ridge, J A et al. (1998) Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol 16:745-53

Showing the most recent 10 out of 14 publications